Trial
NCT03705637
Liposomal Bupivicaine for Skin Graft Donor Sites in Burn Patients
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Burns
Intervention
Exparel
Why stopped
Patient population too low to reasonably continue study, pandemic had started at time of cessation, further leading to study discontinuation.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-02